Apexigen Inc. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.
The company stated in the following report that they exploit animals for product testing.
“Rabbits offer numerous advantages over other animal species for the generation of therapeutic antibodies.” (Page 109) Read the full document
Apexigen, Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Apexigen serves customers in the United States.
Company Website: https://www.apexigen.com